Trial Profile
Clinical Trials Insight: 700016483
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Oct 2006
Price :
$35
*
At a glance
- Drugs G 4460 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors Genta (CEASED)
- 19 Oct 2006 New trial record.